
It’s Simple: Point-of-Care Testing Improves Access
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, discusses how point-of-care testing improves access to both diagnostics and treatment with Seth Egan, co-founder of and chief commercialization officer for Co-Diagnostics.
Among the topics they cover in their wide-ranging conversation:
- How and why point-of-care testing improves both diagnostic and treatment access.
- The key equation of simplicity, cost, and turnaround time (TAT) as the means of providing point-of-care testing.
- The rationale behind the menu of tests Co-Diagnostics is developing.
- The role of clinical labs in point-of-care testing continuum.
- The future of point-of-care testing.
Further listening: How You Can Harness AI in Your Laboratory
Pas encore de commentaire